Clinical Trials Directory

Trials / Unknown

UnknownNCT05925283

Clinical Study of Oral Midazolam Combined With Esketamine Administered Intranasally for Pediatric Preoperative Sedation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
126 (estimated)
Sponsor
Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
Sex
All
Age
2 Years – 6 Years
Healthy volunteers
Accepted

Summary

Children are prone to anxiety and even fear before surgery, and such adverse emotions may not only lead to poor induction of anesthesia, but also increase the incidence of postoperative agitation and even lead to postoperative behavioral changes in children. There are many ways to relieve pediatric anxiety, including preoperative medication, games, and cartoons. Preoperative medication is the most commonly used method to relieve pediatric anxiety.The most commonly used pediatric preoperative sedation drugs are midazolam and esketamine.However, oral midazolam may not produce a sedative effect in 20-40% of patients. A good preoperative anxiety-reducing effect was seen in only 60-80% of cases.Therefore, this trial investigates whether the intranasal combination of esketamine with oral midazolam can produce better results than each of the two drugs alone. This will provide a reference for the selection of safe, reliable and appropriate preoperative sedation methods for pediatric patients and provide evidence-based support for comfort care.

Detailed description

A trained member of the research team obtained a baseline The Modified Yale Preoperative Anxiety Scale(mYPAS) after obtaining consent. And corresponding study medication is administered about 30-40 minutes before the anesthesia induction.Vital signs were measured every 5 min after study medication administration.The sedation scores of the children were recorded with University of Michigan Sedation Scale (UMSS) every 10 minutes.The onset time of satisfactory sedation and parental separation anxiety scale was noted.Then recorded the degree of cooperation during inhalation anesthesia induction and recovery times.Moreover, recorded the pediatric anesthesia emergence delirium scale (PAED) during the recovery period.

Conditions

Interventions

TypeNameDescription
DRUGMidazolamoral midazolam 0.5mg.kg-1 approximately 30-40 minutes before surgery using a computer-generated random number table.
DRUGEsketamineintranasal esketamine 1mg/kg approximately 30-40 mins before surgery using a computer-generated random number table.
DRUGmidazolam and esketamineoral midazolam 0.3mg/kg and intranasal esketamine 0.6mg/kg approximately 30-40 mins before surgery using a computer-generated random number table.

Timeline

Start date
2023-06-30
Primary completion
2023-11-30
Completion
2024-03-30
First posted
2023-06-29
Last updated
2023-06-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05925283. Inclusion in this directory is not an endorsement.